Form 8-K ABBOTT LABORATORIES For: Apr 17

Go back to Form 8-K ABBOTT LABORATORIES For: Apr 17

Abbott Labs (ABT) PT Lowered to $125 at RBC Capital

April 18, 2024 6:19 AM EDT

RBC Capital analyst Shagun Singh lowered the price target on Abbott Labs (NYSE: ABT) to $125.00 (from $128.00) while maintaining a Outperform rating.

The analyst comments "ABT delivered a Q1 Rev/EPS upside of $80MM/$0.03, respectively, and tightened its FY24 guidance range. Despite a strong Q1... More